Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of the company. The firm is also engaged in the animal health businessthrough its Stem Animal Health subsidiary.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Summary  rate and reply

Great read on biotech sector!  rate and reply

Neovasc Announces Second Quarter Financial Results

Generated revenues of $818,000, a quarterly record and a year-over-year increase of 29% over the second quarter of 2021. And COSIRA II protocol supplement was approved by the FDA, more than doubling the total number of patients and adding specific patient groups eligible and allowed for treatment in the trial. more

Important Quote

" Kane is collaborating with the FDA on our coactiv+™ 510(k) application for which a positive pre-submission meeting was recently held and a clear path forward was established" more

Kane Biotech to close fully subscribed private placement  rate and reply

Insider buying

Kane Biotech Announces Update on Private Placement   May 06, 2022 08:30 ET  | Source: Kane Biotech Inc. more


Despite the high volume dump post news, the validation flowing from the certification and subsequent tangible increased revenue flows is significant and lowers the investment risk.   rate and reply


And not a very exciting news release.  rate and reply


Pending news  rate and reply

RE:RE:RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements

I like this CEO, he has surrounded himself with competent people and is unafraid to shift the reigns to them. There is a definitive direction for the company in niche space, with contracts in more

RE:RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements

no problem.  Kane has another patent appliction published  Bibliographic data: US2022054383 (A1) 2022-02-24 |   In my patents list | Previous more

RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements

Yes your right, I missed it. Happy and rieved to see it actually, a BioTech implementing a business plane with targeted segments. Just never stood out for me and I remember reading the more

RE:RE:RE:Kane Biotech Announces New Collaboration Agreements

also it was plainly in this statment from 2nd Q 2021 MD&A  released Aug 26th 2021 which is the same statement made on the year end 2020 MD&A released Mar 25th 2021....frankly more

RE:RE:Kane Biotech Announces New Collaboration Agreements

mirrirworldman take a look at this at 3:44 in...the slide from a prevoius/ old presentation plainly shows the prosthetic joints etc issue as a target. Also at the end at 7:00 gives some of the more

RE:Kane Biotech Announces New Collaboration Agreements

Looks like an investigator initiated trial designed to flow cash to the doctor and perhaps supply a tiny bit of human evidence to Kane.  Its odd that this market did not come up on the Radar more

Kane Biotech Announces New Collaboration Agreements

WINNIPEG, Manitoba, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has signed collaboration agreements with Dr. James Doub, MD, Assistant Professor of Medicine, University more

Volume is picking up...a little

Daily and weekly volume (all stock exchanges) is picking up. We are well overdue for an update regarding the following topics; 1. Animalcare (sales and production); 2. New veterinarian more

Summary  rate and reply


Snippets related to STEM from AnimalCares Group’s recent release.   28 September 2021. Animalcare Group plc ("the Company" or "Group") (AIM: ANCR), more

yet another DispersinB patent application published Bibliographic more


new patent application filed  STABLE LIQUID DISPERSINB COMPOSITIONS more